Drawing for MEDBUDDY

USPTO serial 98787674

MEDBUDDY

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
ANKRAH, NAAKWAMA S
Law office
TMEG LAW OFFICE 109

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDBUDDY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable audio recordings featuring INFORMATION ABOUT TOY PRODUCTS DESIGNED TO BE USED IN THE MEDICAL FIELD IN CONJUNCTION WITH INJECTIONS, VACCINATIONS, AND OTHER MEDICAL PROCEDURES, ALONG WITH INSTRUCTIONAL VIDEOS AS WELL AS CHARACTER-DRIVEN CONTENT AND MEDIA TO ENHANCE THE USER EXPERIENCE; Downloadable audio and video recordings featuring INFORMATION ABOUT TOY PRODUCTS DESIGNED TO BE USED IN THE MEDICAL FIELD IN CONJUNCTION WITH INJECTIONS, VACCINATIONS, AND OTHER MEDICAL PROCEDURES, ALONG WITH INSTRUCTIONAL VIDEOS AS WELL AS CHARACTER-DRIVEN CONTENT AND MEDIA TO ENHANCE THE USER EXPERIENCE authenticated by non-fungible tokens (NFTs); Downloadable cartoon strips; Downloadable comics; Downloadable educational media, namely, audio files, video recordings, and multimedia files featuring INFORMATION ABOUT TOY PRODUCTS DESIGNED TO BE USED IN THE MEDICAL FIELD IN CONJUNCTION WITH INJECTIONS, VACCINATIONS, AND OTHER MEDICAL PROCEDURES, ALONG WITH INSTRUCTIONAL VIDEOS AS WELL AS CHARACTER-DRIVEN CONTENT AND MEDIA TO ENHANCE THE USER EXPERIENCE; Downloadable game software; Downloadable multimedia files containing video relating to INFORMATION ABOUT TOY PRODUCTS DESIGNED TO BE USED IN THE MEDICAL FIELD IN CONJUNCTION WITH INJECTIONS, VACCINATIONS, AND OTHER MEDICAL PROCEDURES, ALONG WITH INSTRUCTIONAL VIDEOS AS WELL AS CHARACTER-DRIVEN CONTENT AND MEDIA TO ENHANCE THE USER EXPERIENCEACTIVEApr 9, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 17, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 17, 2026EX1GSOU EXTENSION 1 GRANTED—
Sep 24, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 25, 2026IUAFUSE AMENDMENT FILED—
May 25, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 25, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 25, 2026NREVNOTICE OF REVIVAL - E-MAILED—
May 25, 2026PETGPETITION TO REVIVE-GRANTED—
May 25, 2026PROATEAS PETITION TO REVIVE RECEIVED—
May 25, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 25, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 21, 2026EXT1SOU EXTENSION 1 FILED—
Oct 21, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 26, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 26, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 11, 2025DOCKASSIGNED TO EXAMINER—
Apr 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 7, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance